Poor Prognosis of Young Adults with Type 1 Diabetes: a Longitudinal Study
Overview
Affiliations
Objective: To determine the role of early behavioral and psychological factors on later outcomes in young adults with childhood- or adolescent-onset type 1 diabetes.
Research Design And Methods: We conducted a longitudinal cohort study of patients recruited from the register of the young adult outpatient diabetes clinic, Oxford, U.K. A total of 113 individuals (51 male subjects) aged 17-25 years completed assessments, and 87 (77%) were reinterviewed as older adults (aged 28-37 years). Longitudinal assessments were made of glycemic control (HbA(1c)) and complications. Psychological state at baseline was assessed using the Present State Examination and self-report Symptom Checklist, with corresponding interview schedules administered at follow-up.
Results: There was no significant improvement between baseline and follow-up in mean HbA(1c) levels (8.5 vs. 8.6% in men, 9.3 vs. 8.7% in women). The proportion of individuals with serious complications (preproliferative or laser-treated retinopathy, proteinuria or more severe renal disease, peripheral neuropathy, and autonomic neuropathy) increased from 3-37% during the 11-year period. Women were more likely than men to have multiple complications (23 vs. 6%, difference 17%, 95% CI 4-29%, P = 0.02). Psychiatric disorders increased from 16 to 28% (20% in men, 36% in women at follow-up, difference NS), and 8% had psychiatric disorders at both assessments. Baseline psychiatric symptom scores predicted follow-up scores (beta = 0.32, SE [beta] 0.12, P = 0.008, 95% CI 0.09-0.56) and recurrent admissions with diabetic ketoacidosis (odds ratio 9.1, 95% CI 2.9-28.6, P < 0.0001).
Conclusions: The clinical and psychiatric outcome in this cohort was poor. Psychiatric symptoms in later adolescence and young adulthood appeared to predict later psychiatric problems.
Navigating the transition: assessing continuity and loss in endocrinology care.
Nursoy H, Hocaoglu E, Yasar M, Saridas F, Karatoprak K, Gul O Endocr Connect. 2025; 14(4).
PMID: 39998457 PMC: 11906147. DOI: 10.1530/EC-24-0541.
Onisiforou A, Zanos P Comput Struct Biotechnol J. 2024; 23:3610-3624.
PMID: 39493502 PMC: 11530817. DOI: 10.1016/j.csbj.2024.10.011.
Agarwal S, Mathias P, Schechter C, Finnan M, Greenberg M, Leung S Diabetes Care. 2024; 47(11):1995-2001.
PMID: 39288191 PMC: 11502524. DOI: 10.2337/dc24-1346.
Basch M, Lupini F, Ho S, Dagnachew M, Gutierrez-Colina A, Kelly K J Pediatr Psychol. 2024; 49(10):769-779.
PMID: 39212647 PMC: 11493139. DOI: 10.1093/jpepsy/jsae071.
Carcone A, Holtz B, Reardon M, Vesey D, Ellis D, Parks M JMIR Form Res. 2024; 8:e55650.
PMID: 39110496 PMC: 11339569. DOI: 10.2196/55650.